Guangzhou, China

Yudan Shi

This inventor holds 1 USPTO granted patent. Top assignee: Guangzhou Imd Therapeutics Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yudan Shi. Retrieved from https://idiyas.com/inventor/yudan-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yudan Shi: Innovator in Pharmaceutical Compounds

Introduction

Yudan Shi is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzidine compounds. His research focuses on developing compounds that can be utilized in the treatment of various diseases.

Latest Patents

Yudan Shi holds 1 patent for a benzidine compound and its applications. This patent details a benzidine compound with a specific structure, which can be used in the preparation of drugs aimed at treating or preventing RORγ-regulated diseases. Additionally, the compound has potential applications in addressing inflammation, immune diseases, cancer, and neurological disorders.

Career Highlights

Yudan Shi is associated with Guangzhou Imd Therapeutics Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and the pursuit of effective therapeutic solutions.

Collaborations

Yudan collaborates with notable colleagues, including Yong Xu and Yan Zhang, who contribute to his research endeavors and help drive forward the mission of their organization.

Conclusion

Yudan Shi's contributions to the field of pharmaceuticals through his innovative benzidine compound highlight his role as a key inventor in the industry. His work has the potential to impact the treatment of various diseases significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…